top of page

Search Results

Results found for "Inversago Pharma"

  • Brendan Wilkins | Dr. GPCR Ecosystem

    training at the University of New South Wales (UNSW) Sydney, Australia in 2016 with first class Honours in Pharmacology This project aims to characterise the molecular pharmacology of GPR146 and to validate the proposed ligands

  • Dr. Stuart Maudsley | Dr. GPCR Ecosystem

    Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree in Pharmacology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology

  • Dr. Adriano Marchese | Dr. GPCR Ecosystem

    Adriano received his Bachelor of Science degree in Pharmacology in 1991 from the University of Toronto his graduate studies at the University of Toronto where he earned his MSc (1994) and Ph.D. (1998) in Pharmacology In 2004 Adriano joined the faculty of the Department of Pharmacology at Loyola University Chicago.

  • Biased agonism at the GLP-1 receptor: from structure to animal models of disease

    He is a 2022 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology corresponding member of NC-IUPHAR, a member of the Faculty of 1000 and an elected Fellow of the British Pharmacological

  • Dr. Yamina Berchiche | Dr. GPCR Ecosystem

    The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide

  • Dr. Michel Bouvier | Dr. GPCR Ecosystem

    Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology

  • irreversible drugs post 1 | Dr. GPCR Ecosystem

    Join Terry’s Corner and master irreversible pharmacology for modern discovery programs. Unlike reversible ligands, their impact can persist long after the compound is gone — creating durable pharmacological effects that reshape how pharmacokinetics and pharmacodynamics intersect. Those who master kinetic pharmacology set the pace. 🟢 Join Terry’s Corner and sharpen your pharmacology GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #MedicinalChemistry #PKPD #ReceptorKinetics

  • ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem

    This kind of predictive modeling challenges the traditional role of computation in pharmacology, where That scientific humility (combined with deep collaborations with medicinal chemists and pharmacologists This episode is essential listening for anyone thinking seriously about translational pharmacology and

  • Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem

    How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute of Pharmaceutical Michelle earned her PhD in Molecular Pharmacology at Monash University, then trained in single-cell biology and the 2019 Faculty Future Research Leader Award. ⸻ More about Michelle Halls Monash Institute of Pharmaceutical

  • Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity

    Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA 2 Department of Pharmacology Lange and Annie Mary Lyle Chair in Cardiovascular Research, and Professor of Pharmacology, Ophthalmology This is one of the top Pharmacology departments in the country, judged by reputation, citation analysis

  • Dr. Lauren M. Slosky | Dr. GPCR Ecosystem

    Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab research awards, including the William James Psychology Award, the Hank Yamamura Endowed Fellowship in Pharmacology She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

  • Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem

    Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology in the same university that was conferred in 2009. He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

  • Dr. Kathryn E Livingston | Dr. GPCR Ecosystem

    Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology

  • Dr. Kevin Pfleger | Dr. GPCR Ecosystem

    Pfleger trained as a pharmacologist and obtained his Ph.D. at the University of Edinburgh. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

  • Dr. Gregory Tall | Dr. GPCR Ecosystem

    Tall joined the faculty in the Department of Pharmacology and Physiology at the University of Rochester Tall moved to the University of Michigan in 2016 as an Associate Professor of Pharmacology and is a current

  • ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem

    screening compounds, or designing next-gen molecules, this insight reframes what “success” in computational pharmacology

  • Dr. Ross Cheloha | Dr. GPCR Ecosystem

    Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and

  • Dr. Patrick Sexton | Dr. GPCR Ecosystem

    Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council He is a 2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology division) and an elected Fellow of the British Pharmacological Society (BPS). Sexton’s awards include the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists

  • Targeting adenosine signaling for immuno-oncology

    Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Faculté de Pharmacie. 900 St-Denis About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the

  • Dr. Antonella Di Pizio | Dr. GPCR Ecosystem

    Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand

  • Dr. Paul Insel | Dr. GPCR Ecosystem

    Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

  • Dr. Maria Waldhoer | Dr. GPCR Ecosystem

    She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology

  • Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    About Yuling Feng "I am currently a postdoctoral research fellow working with aGPCR pharmacology and unclear which domains of ADGRG6 are N-glycosylated and how this might affect the overall molecular pharmacology

  • How GPCR Spatial Signaling Sparked a Scientific Journey | Dr. GPCR Ecosystem

    From reluctant intern to scientific leader From local signaling to spatial pharmacology From spark to #GPCR #DrGPCR #SpatialSignaling #Pharmacology #DrugDiscovery #ScientificLeadership #Biotech Previous

  • Dr. John Streicher | Dr. GPCR Ecosystem

    John Streicher from the department of pharmacology at the University of Arizona. John Streicher on the web University of Arizona Department of Pharmacology Google Scholar Pubmed LinkedIn

  • Dr. Tobi Langenhan | Dr. GPCR Ecosystem

    animal models (mainly D. melanogaster) and in vitro techniques to pick apart the physiological and pharmacological individual adhesion GPCRs, and extends to the development of novel screening approaches to identify pharmacological

  • From Pipettes to Platforms The Evolution of GPCR Research | Dr. GPCR Ecosystem

    and insights: https://www.ecosystem.drgpcr.com/gpcr-university-pricing #GPCR #DrGPCR #DrugDiscovery #Pharmacology

  • Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem

    Gaetan Guillemette in the Pharmacology department at the Université de Sherbrooke. The pharmacology of latrophilins brings about a great deal of challenges given that they are highly polymorphic

  • Dr. Graciela Pineyro | Dr. GPCR Ecosystem

    Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological

  • Dr. Kathleen Caron | Dr. GPCR Ecosystem

    Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology

bottom of page